Literature DB >> 25620047

Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.

Jason M Garnreiter1, Thomas A Pilcher2, Susan P Etheridge2, Elizabeth V Saarel2.   

Abstract

BACKGROUND: Inappropriate implantable cardioverter-defibrillator (ICD) shocks are a common and significant problem in pediatric patients and patients with congenital heart disease (CHD).
OBJECTIVE: The purpose of this study was to evaluate the effect of programming high detection rates and long detection duration on inappropriate shocks in this population.
METHODS: We performed a retrospective review of all patients with ICDs at a single pediatric center. Inappropriate shocks were defined as a shock for any rhythm except ventricular tachycardia or fibrillation.
RESULTS: A total of 144 patients were included, 63 (44%) with CHD. At implant, mean age and weight were 17 ± 10 years and 57 ± 23 kg. ICDs were single chamber in 35 (24%), dual chamber in 97 (67%), and biventricular in 12 (8%). The mean follow-up duration was 42 ± 39 months. Appropriate shocks occurred in 29 (20.1%) and inappropriate shocks in 14 (9.7%). Causes of inappropriate shocks were supraventricular tachycardia (n = 6), lead malfunction (n = 4), sinus tachycardia (n = 3), and T-wave oversensing (n = 1). The mean ventricular fibrillation detection rate was 222 ± 15 beats/min, and the detection duration was 18 ± 12 beats. Patients with shocks programmed in the ventricular tachycardia zone were more likely to receive an inappropriate shock (P = .03). There were no associations between inappropriate shocks and age or weight at implant, presence of CHD, dual-chamber vs single-chamber device, history of supraventricular tachycardia, or antiarrhythmic use. There were no adverse events as a result of programming.
CONCLUSION: Programming high detection rates and long detection duration resulted in a low rate of inappropriate shocks without associated adverse events in this large cohort of pediatric and CHD patients with ICDs.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Implantable cardioverter-defibrillator; Inappropriate shocks; Pediatrics

Mesh:

Year:  2015        PMID: 25620047     DOI: 10.1016/j.hrthm.2015.01.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  4 in total

1.  Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study.

Authors:  Gabrielle Norrish; Henry Chubb; Ella Field; Karen McLeod; Maria Ilina; Georgia Spentzou; Jan Till; Piers E F Daubeney; Alan Graham Stuart; Jane Matthews; Dominic Hares; Elspeth Brown; Katie Linter; Vinay Bhole; Krishnakumar Pillai; Michael Bowes; Caroline B Jones; Orhan Uzun; Amos Wong; Arthur Yue; Shankar Sadagopan; Tara Bharucha; Norah Yap; Eric Rosenthal; Sujeev Mathur; Satish Adwani; Zdenka Reinhardt; Jasveer Mangat; Juan Pablo Kaski
Journal:  Europace       Date:  2021-03-08       Impact factor: 5.214

Review 2.  Assessing Candidacy for Primary Preventative Implantable Cardioverter-defibrillators in Pediatric Patients with Ion Channelopathies: Weighing the Risks and Benefits.

Authors:  Madeline L Townsend; Peter F Aziz
Journal:  J Innov Card Rhythm Manag       Date:  2018-09-15

3.  Peak Oxygen Uptake on Cardiopulmonary Exercise Test Is a Predictor for Severe Arrhythmic Events during Three-Year Follow-Up in Patients with Complex Congenital Heart Disease.

Authors:  Felix von Sanden; Svetlana Ptushkina; Julia Hock; Celina Fritz; Jürgen Hörer; Gabriele Hessling; Peter Ewert; Alfred Hager; Cordula M Wolf
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-04

4.  Hypoplastic coronary artery disease and hypertension in a child: a case report.

Authors:  Yuji Doi; Kenji Waki; Kayo Ogino; Tomohiro Hayashi
Journal:  Eur Heart J Case Rep       Date:  2021-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.